Jpmorgan Chase & CO Biotechnology

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EQ Equillium, Inc.	$46M	$0 0.0% of portfolio	38	Q1 2025 Reduced 7.32%
FGEN Fibrogen Inc	$989M	$0 0.0% of portfolio	1,223	Q1 2025 Added 115.7%
GLYC Glycomimetics Inc	$823M	$0 0.0% of portfolio	126	Q1 2025 Reduced 7.35%
IMMX Immix Biopharma, Inc.	$34.8M	$0 0.0% of portfolio	35	Q1 2025 Reduced 7.89%
ICCC Immucell Corp	$52.7M	$0 0.0% of portfolio	10	Q1 2025 Reduced 9.09%
INAB In8 Bio, Inc.	$51.5M	$0 0.0% of portfolio	102	Q1 2025 Reduced 8.93%
INDP Indaptus Therapeutics, Inc.	$32.4M	$0 0.0% of portfolio	17	Q1 2025 Reduced 10.53%
KRON Kronos Bio, Inc.	$50M	$0 0.0% of portfolio	441	Q1 2025 Reduced 1.56%
LTRN Lantern Pharma Inc.	$47M	$0 0.0% of portfolio	128	Q1 2025 New
MAIA Maia Biotechnology, Inc.	$16.6M	$0 0.0% of portfolio	42	Q1 2025 Reduced 6.67%
MREO Mereo Biopharma Group PLC	$245M	$0 0.0% of portfolio	365	Q1 2024 Added 10,344.38%
NERV Minerva Neurosciences, Inc.	$12.5M	$0 0.0% of portfolio	17	Q4 2024 New
NXTC Next Cure, Inc.	$185M	$0 0.0% of portfolio	807	Q1 2025 Added 0.25%
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	58	Q1 2025 New
PASG Passage Bio, Inc.	$461M	$0 0.0% of portfolio	592	Q1 2025 Added 116.85%
PDSB Pds Biotechnology Corp	$27M	$0 0.0% of portfolio	619	Q1 2024 Added 1,809.85%
PMCB Pharma Cyte Biotech, Inc.	$20.8M	$0 0.0% of portfolio	16	Q1 2025 Reduced 11.11%
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	547	Q1 2025 Added 0.37%
RLYB Rallybio Corp	$16.4M	$0 0.0% of portfolio	944	Q1 2025 Reduced 0.42%
RANI Rani Therapeutics Holdings, Inc.	$11.3M	$0 0.0% of portfolio	71	Q1 2024 Added 17,767.61%
RLMD Relmada Therapeutics, Inc.	$58.4M	$0 0.0% of portfolio	158	Q1 2025 Reduced 99.58%
RNXT Renovo Rx, Inc.	$10.1M	$0 0.0% of portfolio	36	Q1 2025 Reduced 10.0%
RPTX Repare Therapeutics Inc.	$75.5M	$0 0.0% of portfolio	4	Q1 2025 Reduced 100.0%
SNSE Sensei Biotherapeutics, Inc.	$346M	$0 0.0% of portfolio	702	Q1 2025 Reduced 0.43%
MCRB Seres Therapeutics, Inc.	$2.37B	$0 0.0% of portfolio	1,304	Q1 2024 Added 2,924.77%
SPRB Spruce Biosciences, Inc.	$4.09B	$0 0.0% of portfolio	65	Q1 2025 Reduced 5.8%
TPST Tempest Therapeutics, Inc.	$107M	$0 0.0% of portfolio	77	Q1 2025 New
TLSA Tiziana Life Sciences LTD	$209M	$0 0.0% of portfolio	100	Q1 2025 New
UNCY Unicycive Therapeutics, Inc.	$66.8M	$0 0.0% of portfolio	184	Q1 2025 Reduced 7.54%
VXRT Vaxart, Inc.	$44.3M	$0 0.0% of portfolio	2,214	Q1 2024 Added 5,436.18%
VIGL Vigil Neuroscience, Inc.	$228M	$0 0.0% of portfolio	382	Q4 2024 Reduced 7.73%
XLO Xilio Therapeutics, Inc.	$21.7M	$0 0.0% of portfolio	62	Q1 2025 Reduced 6.06%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.